• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[A systematic review of MA versus IA regimen for patients with acute myelogenous leukemia].

作者信息

Wang Wen-juan, Sun Ai-ning, Qiu Hui-ying

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2011 Dec;32(12):869-70.

PMID:22339965
Abstract
摘要

相似文献

1
[A systematic review of MA versus IA regimen for patients with acute myelogenous leukemia].
Zhonghua Xue Ye Xue Za Zhi. 2011 Dec;32(12):869-70.
2
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients.中剂量阿糖胞苷联合米托蒽醌与标准剂量阿糖胞苷联合柔红霉素治疗老年急性髓系白血病的比较。
Ann Oncol. 2018 Apr 1;29(4):973-978. doi: 10.1093/annonc/mdy030.
3
Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7 + 3) in newly diagnosed high-risk acute myeloid leukemia (AML).一项关于阿沃西地布、阿糖胞苷和米托蒽醌对比阿糖胞苷和柔红霉素（7+3）用于新诊断高危急性髓系白血病（AML）的随机多中心II期研究的最终结果。
Leuk Res. 2018 Sep;72:92-95. doi: 10.1016/j.leukres.2018.08.005. Epub 2018 Aug 10.
4
Fulminant hepatic failure after high-dose cytosine arabinoside and mitoxantrone treatment for relapse of acute myelogenous leukaemia.高剂量阿糖胞苷和米托蒽醌治疗急性髓性白血病复发后出现暴发性肝衰竭。
Eur J Haematol. 1992 Oct;49(4):221-3. doi: 10.1111/j.1600-0609.1992.tb00052.x.
5
Mitoxantrone and cytarabine versus daunorubicin and cytarabine in previously untreated patients with acute myeloid leukemia.米托蒽醌与阿糖胞苷联合方案对比柔红霉素与阿糖胞苷联合方案用于初治急性髓系白血病患者的疗效
Cancer Chemother Pharmacol. 1991;28(6):480-3. doi: 10.1007/BF00685827.
6
High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial.大剂量阿糖胞苷巩固治疗联合或不联合安吖啶和米托蒽醌治疗急性髓系白血病：前瞻性随机 AML2003 试验的结果。
J Clin Oncol. 2013 Jun 10;31(17):2094-102. doi: 10.1200/JCO.2012.46.4743. Epub 2013 Apr 29.
7
Continuous 24-h monitoring of electrocardiogram during anthracycline-based therapy in acute leukemia.急性白血病蒽环类药物治疗期间的24小时连续心电图监测。
Leuk Res. 2009 Aug;33(8):e109-10. doi: 10.1016/j.leukres.2008.12.024. Epub 2009 Feb 23.
8
Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group.急性髓系白血病的双重诱导策略：高剂量阿糖胞苷联合米托蒽醌替代标准剂量阿糖胞苷联合柔红霉素及6-硫鸟嘌呤的疗效：德国急性髓系白血病协作组的一项随机试验
Blood. 1999 Jun 15;93(12):4116-24.
9
Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen.接受急性髓系白血病缓解诱导治疗的成人侵袭性真菌病：抗白血病方案的致病作用
Clin Infect Dis. 1995 Aug;21(2):361-9. doi: 10.1093/clinids/21.2.361.
10
Efficacy of common salvage chemotherapy regimens in patients with refractory or relapsed acute myeloid leukemia: A retrospective cohort study.常用挽救性化疗方案对难治性或复发性急性髓系白血病患者的疗效：一项回顾性队列研究。
Medicine (Baltimore). 2018 Sep;97(39):e12102. doi: 10.1097/MD.0000000000012102.

引用本文的文献

1
Observation of clinical efficacy and toxic and side effects of pirarubicin combined with cytarabine on acute myeloid leukemia.吡柔比星联合阿糖胞苷治疗急性髓系白血病的临床疗效及毒副作用观察
Oncol Lett. 2019 Mar;17(3):3411-3417. doi: 10.3892/ol.2019.9966. Epub 2019 Jan 24.
2
[Comparison of 10 mg/m² or 8 mg/m² idarubicin plus cytarabine regimen as induction chemotherapy for adult patients with newly diagnosed acute myeloid leukemia].[10mg/m²或8mg/m²伊达比星联合阿糖胞苷方案作为新诊断成人急性髓系白血病诱导化疗的比较]
Zhonghua Xue Ye Xue Za Zhi. 2015 Mar;36(3):225-9. doi: 10.3760/cma.j.issn.0253-2727.2015.03.011.